Manchester, United Kingdom · Founded 2007 · Privately Held (backing)
Developer of a medical device designed to provide treatment of acute dysphagia. Phagenesis is based in Manchester, United Kingdom and was founded in 2007. Its last reported valuation was $51.3 million in Aug 2025. It has raised $90 million.
Last reported valuation
$51.3M
Oct 2026
Priced at
—
Total raised
$90.0M
Last round
—
Team — not yet on record
No current team members for Phagenesis are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Phagenesis with a free account
·The complete investor list: 11 names
·Watch Phagenesis: the Monday email on marks, rounds and moves
